ConforMIS Inc. (NASDAQ:CFMS) was down 5.9% during trading on Wednesday . The company traded as low as $7.38 and last traded at $7.52, with a volume of 268,525 shares trading hands. The stock had previously closed at $7.99.

A number of equities research analysts recently commented on CFMS shares. Oppenheimer Holdings Inc. started coverage on ConforMIS in a research report on Saturday, May 14th. They issued a “buy” rating for the company. Canaccord Genuity reissued a “buy” rating on shares of ConforMIS in a research report on Saturday, May 14th. Deutsche Bank AG lowered their price target on ConforMIS from $26.00 to $12.00 and set a “buy” rating for the company in a research report on Friday, May 13th. Zacks Investment Research raised ConforMIS from a “sell” rating to a “hold” rating in a research report on Friday, June 24th. Finally, Wells Fargo & Co. lowered ConforMIS from an “outperform” rating to a “market perform” rating in a research report on Friday, May 13th. Three equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. The stock currently has an average rating of “Buy” and a consensus target price of $15.20.

The firm has a 50 day moving average of $7.27 and a 200 day moving average of $10.06. The stock’s market capitalization is $306.75 million.

ConforMIS (NASDAQ:CFMS) last released its quarterly earnings results on Thursday, May 12th. The company reported ($0.37) earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.38) by $0.01. The firm had revenue of $20.30 million for the quarter, compared to the consensus estimate of $19.23 million. The business’s revenue was up 38.1% compared to the same quarter last year. On average, equities research analysts forecast that ConforMIS Inc. will post ($1.38) earnings per share for the current year.

A hedge fund recently raised its stake in ConforMIS stock. Wells Fargo & Company MN boosted its stake in shares of ConforMIS Inc. (NASDAQ:CFMS) by 38.7% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 501,056 shares of the company’s stock after buying an additional 139,708 shares during the period. Wells Fargo & Company MN owned about 1.23% of ConforMIS worth $8,663,000 as of its most recent SEC filing.

ConforMIS, Inc is a medical technology company that uses its iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants. The Company’s products include iTotal CR, which is the cruciate-retaining, customized total knee replacement system to restore the natural shape of a patient’s knee; iTotal PS, which is the posterior cruciate ligament substituting, or posterior-stabilized, customized total knee replacement product to restore the natural shape of a patient’s knee; iDuo, which is the customized bicompartmental knee replacement system, and iUni, which is the customized unicompartmental knee replacement product for treatment of the medial or lateral compartment of the knee.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.